Outcomes of Innovative Programmed Treatment of Children with Malignant Loco-Motor System Tumors in Moscow



Cite item

Full Text

Abstract

During the period from 2005 to 2010 forty nine patients from Moscow city aged 1 — 16 years (mean age 9.4 years) were treated for malignant tumors (MT) of loco-motor system. Localized process was diagnosed in 25 (51%) patients, IV stage of disease in 24 (49%) children. Use of adopted treatment program including intensive polychemotherapy, organ-saving surgical treatment and radiotherapy enabled to achieve optimistic results. Overall 2-years survival rate for children with loco-motor system MT made up 64.3±7.2%, i.e. 86.5±7.2% in localized and 42.6±10.5% in disseminated process.

Full Text

Результаты инновационного программного лечения детей со злокачественными опухолями опорно-двигательного аппарата в городе Москве
×

References

  1. Fletcher C.D.M., Unni K.K., Mertens F. Pathology and genetics of tumours of soft tissue and Bone. Lyon: IARC Press; 2002.
  2. Дурное Л.А. Руководство по детской онкологии. М.: Миклош; 2003: 15.
  3. Давыдов М.И. Энциклопедия клинической онкологии. М.: ООО «РЛС-2004; 2004: 738.
  4. Дурное Л.А., Голдобенко Г.В. Детская онкология. М.: Медицина; 2002: 382-3.
  5. Блинов И.М., Павловская А.И., Соловьев Ю.Н. Злокачественная фиброзная гистиоцитома кости. Архив патологии. 1981; 10: 25-33.
  6. Fearnow E.C., De Luca S.A. Malignant fibrous histiocytoma of bone. Am. Fan. Physician. 1989; 39 (2): 209-11.
  7. Lewis V.O. What’s new in musculoskeletal oncology. J. Bom Jt Surg. Am. 2007; 89 (6): 1399-1407.
  8. Ferrari A., Sultan I., Huang T.T., Rodriguez-Galindo C., Shehadeh A., Meazza C. et al. Soft tissue sarcoma across the age spectrum: a population-based study from the surveillance epidemiology and end results database. Pediatr. Blood Cancer. 2011; 57 (6): 943-9.
  9. Osuna D., de Alava E. Molecular pathology of sarcomas. Rev. Recent. Clin. Trials. 2009; 4 (1): 12-26.
  10. Muhic A., Hovgaard D., M0rk Petersen M., Daugaard S., H0jlund Bech B, Roed H., et al. Local control and survival in patients with soft tissue sarcomas treated with limb sparing surgery in combination with interstitial brachytherapy and external radiation. Radiother. Oncol. 2008; 88 (3): 382-387.
  11. O’Sullivan B., Davis A.M., Turcotte R., Bell R., Catton C., Chabot P. et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet. 2001; 359 (9325): 2235-41.
  12. Eilber F.C., Rosen G., Eckardt J., Forscher C., Nelson S.D., Selch M. et al. Treatment-induced pathologic necrosis: а predictor of local recurrence and survival imptients receiving neoadjuvant therapy for high-grade extremities soft tissue sarcomas. J. Clin. Oncol. 2001; 19 (13): 3203-9.
  13. Bacci G., Briccoli A., Rocca M., Ferrari S., Donati D., Longhi A. et al. Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide. Ann. Oncol. 2003; 14 (7): 1126-34.
  14. Weeden S., Grimer R.J., Cannon S.R., Taminiau A.H., Uscinska B.M. European osteosarcoma intergroup. The effect of local recurrence on survival in resected osteosarcoma. Eur. J. Cancer. 2001; 37 (1): 39-46.
  15. Bielack S.S., Kempf-Bielack B., Delling G., Exner G.U., Flege S., Helmke K. et al. Prognostic factors in highgrade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols J. Clin. Oncol. 2002; 20 (3): 776-90.
  16. Hosalkar H.S., Dormans J.P. Limb sparing surgery for pediatric musculoskeletal tumors. Pediatr. Blood Cancer. 2004; 42 (4): 295-310.
  17. Schrager J., Patzer R.E., Mink P.J., Ward K.C., Goodman M. Survival outcomes of pediatric osteosarcoma and Ewing’s sarcoma: a comparison of surgery type within the SEER database, 1988-2007. J. Registry Manag. 2011; 38 (3): 153-61.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2013 Eco-Vector


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-76249 от 19.07.2019.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies